3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase NA
6
Phase 1/2
3
Phase 1
2
Phase 3
1
Status
Completed
20
Terminated
9
Recruiting
4
Unknown
2
Not yet recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Classical hematology
1
Conditions
Neoplasms
87
Carcinoma, Non-Small-Cell Lung
76
Breast Neoplasms
73
Recurrence
64
Colorectal Neoplasms
63
Pancreatic Neoplasms
60
Melanoma
58
Advanced Solid Tumor
57
Carcinoma, Hepatocellular
56
Multiple Myeloma
55
Lymphoma
53
Leukemia, Myeloid, Acute
53
Advanced Solid Tumors
53
Neoplasm Metastasis
50
Stomach Neoplasms
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44
Lymphoma, B-Cell
40
Solid Tumor
39
Ovarian Neoplasms
38
Lymphoma, Non-Hodgkin
38
Lung Neoplasms
36
Glioblastoma
35
Prostatic Neoplasms
34
Leukemia
28
Head and Neck Neoplasms
27
Leukemia, Lymphocytic, Chronic, B-Cell
26
Uterine Cervical Neoplasms
25
Burkitt Lymphoma
24
Esophageal Neoplasms
23
Urinary Bladder Neoplasms
20
Interventions
venetoclax
1
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Unknown
×
Graft vs Host Disease
×
Clear all
NCT05005299
2023-08-01
VICTORY
Melbourne Health
Phase 1
Unknown
18 enrolled
NCT03836690
2019-10-25
ToTem
University College, London
Phase 1
Unknown
18 enrolled